Bank of America’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Bank of America’s Portfolio ASLN Stock Details ASLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,749	Closed	-$4.2K	–	8584
2024 Q2	$4.2K	Buy	1,749 +1,369	+360%	+$4.85K	﹤0.01%	7043
2024 Q1	$1.87K	Buy	+380	New	+$1.9K	﹤0.01%	7134
2022 Q3	–	Sell	-2,204	Closed	-$44K	–	8305
2022 Q2	$44K	Sell	2,204 -4,289	-66%	-$95.1K	﹤0.01%	6899
2022 Q1	$233K	Buy	6,493 +1,664	+34%	+$61.9K	﹤0.01%	6385
2021 Q4	$216K	Buy	+4,829	New	+$289K	﹤0.01%	6458
2021 Q2	–	Sell	-21	Closed	-$3K	–	8181
2021 Q1	$3K	Buy	+21	New	+$2.66K	﹤0.01%	7208
2020 Q1	–	Sell	-2,019	Closed	-$164K	–	7342
2019 Q4	$164K	Buy	+2,019	New	+$144K	﹤0.01%	5742

Other funds holding ASLN

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Bank of America's ASLN Position: Q3 2024 in Review

Bank of America sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q3 2024, closing a stake of 1,749 shares — an estimated $4.2K sold.

Bank of America first reported a position in ASLN in Q4 2019 and held it in 7 quarters. The position peaked at $233K in Q1 2022. 1 fund tracked by Wall St. Rank holds ASLN as of Q3 2024.

Bank of America reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q3 2024 after selling out during the quarter.
Bank of America sold 1,749 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q3 2024, an estimated $4.2K.
Bank of America first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q4 2019 and held it in 7 quarters.
Bank of America's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $233K in Q1 2022.
1 fund tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q3 2024.

Based on Bank of America's 13F filing for Q3 2024, filed 14 Nov 2024.